Sartorius

Sartorius Stock-Based Compensation

Stock-Based Compensation (SBC) of Sartorius (SRT.DE) as of Oct 27, 2026.

Stock-Based Compensation

0.00EUR

Last updated:

Stock-Based Compensation (SBC) of Sartorius is 2025 0.00 EUR. Stock-Based Compensation (SBC) of Sartorius was 2024 600,000.00 EUR. It decreases by % lower compared to the previous year.

The Sartorius Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2017
1.61 M EUR
Jan 1, 2018
1.54 M EUR
Jan 1, 2019
2.82 M EUR
Jan 1, 2020
3.11 M EUR
Jan 1, 2021
3.10 M EUR
Jan 1, 2022
1.60 M EUR
Jan 1, 2023
600,000.00 EUR
Jan 1, 2025
0.00 EUR
The Sartorius Stock-Based Compensation history
YEARStock-Based CompensationYoY
0.00EUR-100.00%
600,000.00EUR-62.50%
1.60 MEUR-48.39%
3.10 MEUR-0.32%
3.11 MEUR+10.40%
2.82 MEUR+82.45%
1.54 MEUR-3.92%
1.61 MEUR-11.75%
1.82 MEUR-45.82%
3.36 MEUR+392.82%
682,000.00EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Sartorius Stock analysis

What does Sartorius do? Sartorius AG is a globally operating company specializing in the development and manufacturing of laboratory equipment and process technologies. It was founded in 1870 by industrialist and entrepreneur Florenz Sartorius in Göttingen, Germany. The company initially focused on the sale of scales, weights, and measuring instruments but has since expanded and diversified its product line. Today, Sartorius AG is a world leader in the bioprocessing and laboratory equipment sectors and is known for its innovative products and procedures. The company's business model revolves around the development of high-tech products for applications in biotechnology, pharmaceuticals, and the food industry. It operates in two main business segments: Bioprocess Solutions and Lab Products & Services. The Bioprocess Solutions segment provides solutions and services for biopharmaceutical production, including filtration, fermentation, fluid management, and cell cultures. The products in this segment are typically disposable consumables used in the production of biopharmaceutical agents. The Lab Products & Services segment offers a wide range of laboratory equipment, from scales and microbiology equipment to ultrafiltration devices. These instruments are used by researchers and scientists in academic, industrial, and pharmaceutical laboratories worldwide. Furthermore, an important part of Sartorius' portfolio includes bioreactors and fermenters. These specialized devices are used for cultivating cells and microorganisms and are particularly important in biotechnology and vaccine production. Sartorius has established itself as a leader in this field through its innovative and high-performance products. In addition to the pharmaceutical, biotechnology, and laboratory sectors, Sartorius is also active in environmental technology. The company provides products and services for water analysis and purification, which are in demand in industries such as pharmaceuticals, food production, and environmental analysis due to their precise and reliable results. Sartorius demonstrates its innovation through the use of technologies such as machine learning and artificial intelligence. For example, the company offers the "Ambr" solution for fast and reliable modeling of production scenarios for biopharmaceutical agents. Machine learning techniques are employed to generate more data and make better decisions. Overall, Sartorius AG is a global company with a wide range of products and services for the biotechnology, pharmaceutical, chemical, and food industries. The company's innovation is evident in its continuous advancement of procedures, technologies, and products. With a strong market position and clear strategic direction, Sartorius will continue to be an important player in the industry and support the work of researchers and scientists worldwide with its high-performance products. Sartorius is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Sartorius stock

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Sartorius since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Sartorius historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Sartorius

All Key Metrics — Sartorius